Lee-Jen Wei

14PUBLICATIONS

35CO-AUTHORS

Infectious diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 12, 2026

Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

|Mar 28, 2025

Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer.

Xuan Wang, Ethan B Ludmir, Lee-Jen Wei

|Dec 02, 2024

Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.

Stephanie Armbruster, Hicham Skali, Lee-Jen Wei

|Aug 08, 2024

Inferences for the distribution of the duration of response in a comparative clinical study.

Ying Cui, Bo Huang, Lu Mao

|Jun 04, 2024

Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.

Mathew S Maurer, Prem Soman, Adrian Hernandez

|Nov 21, 2023

Assessing Predictability of Pathologic Lymph Node Regression for Recurrence and Survival in Esophageal Adenocarcinoma.

Ryan Sun, Jingyi Liu, Lee-Jen Wei

Pageof 3

Frequent Collaborators

Zachary R McCaw

Lu Tian

Hajime Uno

Bo Huang

Paul G Richardson

Ethan B Ludmir

José M Moraleda

Ying Lu

Keaven M Anderson

Prem Soman

Frequent Collaborators

Zachary R McCaw

Lu Tian

Hajime Uno

Bo Huang